Brief: Evotec And X-Chem Collaborate To Accelerate Early-Stage Drug Discovery
Sept 5 (Reuters) - EVOTEC SE EVTG.DE :
* IN PARTNERSHIP WITH EVOTEC'S SCREENING PLATFORMS AND
CAPABILITIES, X-CHEM IS PROVIDING ACCESS TO ITS DEL TECHNOLOGY,
INCLUDING DELFLEX AND HITMINER (ADDS DROPPED WORDS)
* EVOTEC AND X-CHEM COLLABORATE TO ACCELERATE EARLY-STAGE
DRUG
DISCOVERY
Further company coverage: EVTG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases